These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11463004)

  • 1. Lipoprotein(a) levels in patients with homozygous familial hypercholesterolaemia.
    Miltiadous G; Tsimihodimos V; Bairaktari E; Elisaf M
    Atherosclerosis; 2001 Jul; 157(1):255-6. PubMed ID: 11463004
    [No Abstract]   [Full Text] [Related]  

  • 2. Normal levels of lipoproteins including lipoprotein(a) after liver-heart transplantation in a patient with homozygous familial hypercholesterolaemia.
    Barbir M; Khaghani A; Kehely A; Tan KC; Mitchell A; Thompson GR; Yacoub M
    Q J Med; 1992; 85(307-308):807-12. PubMed ID: 1484944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P
    Circulation; 2017 Aug; 136(9):880-882. PubMed ID: 28847800
    [No Abstract]   [Full Text] [Related]  

  • 4. The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.
    Stefanutti C; Blom DJ; Averna MR; Meagher EA; Theron Hd; Marais AD; Hegele RA; Sirtori CR; Shah PK; Gaudet D; Vigna GB; Sachais BS; Di Giacomo S; du Plessis AM; Bloedon LT; Balser J; Rader DJ; Cuchel M;
    Atherosclerosis; 2015 Jun; 240(2):408-14. PubMed ID: 25897792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein (a) and risk of cardiovascular disease in patients with metabolic syndrome in a population of familial hypercholesterolaemia.
    Rana JS; Jansen AC; Zwinderman AH; van Aalst-Cohen ES; Jukema JW; Trip MD; Kastelein JJ
    J Intern Med; 2006 Aug; 260(2):183-5. PubMed ID: 16882284
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial Hypercholesterolaemia Regression Study and its implications.
    Watts GF
    Lancet; 1995 Apr; 345(8953):807-8. PubMed ID: 7898224
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of lipoprotein apheresis with dextran-sulfate adsorption on the expression of genes involved in cardiovascular health in the blood of patients with homozygous familial hypercholesterolemia.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Laflamme N; Lamarche B; Couture P
    J Clin Apher; 2018 Feb; 33(1):104-107. PubMed ID: 28712132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P
    Atherosclerosis; 2018 Mar; 270():26-32. PubMed ID: 29407885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial defective apolipoprotein B-100: mild hypercholesterolaemia without atherosclerosis in a homozygous patient.
    März W; Ruzicka C; Pohl T; Usadel KH; Gross W
    Lancet; 1992 Nov; 340(8831):1362. PubMed ID: 1360085
    [No Abstract]   [Full Text] [Related]  

  • 10. High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study.
    Langsted A; Kamstrup PR; Benn M; Tybjærg-Hansen A; Nordestgaard BG
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):577-87. PubMed ID: 27185354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of circulating miRNAs in patients with familial hypercholesterolaemia treated by LDL/Lp(a) apheresis.
    Dlouha D; Blaha M; Blaha V; Fatorova I; Hubacek JA; Stavek P; Lanska V; Parikova A; Pitha J
    Atheroscler Suppl; 2017 Nov; 30():128-134. PubMed ID: 29096828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of lipoprotein apheresis in homozygous familial hypercholesterolaemia.
    Meier P; Blanc E
    Nephrol Dial Transplant; 2000 May; 15(5):738-40. PubMed ID: 10809830
    [No Abstract]   [Full Text] [Related]  

  • 13. Familial hypercholesterolaemia: esterification of cholesterol in lymphocytes from homozygous and heterozygous subjects.
    Hammond KD; Khan Q; Mendelsohn D; Seftel HC
    Arch Int Physiol Biochim; 1984 Dec; 92(5):355-60. PubMed ID: 6085551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evidence-base for the efficacy of lipoprotein apheresis in combating cardiovascular disease.
    Thompson GR
    Atheroscler Suppl; 2013 Jan; 14(1):67-70. PubMed ID: 23357143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective apheresis of low-density lipoproteins].
    Griskevicius A; Audzijoniene J
    Medicina (Kaunas); 2006; 42(6):499-503. PubMed ID: 16816545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormal low-density lipoprotein receptor activities in homozygous familial hypercholesterolemic patients].
    Cai HJ
    Zhonghua Yi Xue Za Zhi; 1985 Jun; 65(6):344-8. PubMed ID: 3930023
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevated Lipoprotein(a) and Its Implications for Familial Hypercholesterolemia Diagnosis, Prognosis, and Family Screening.
    Santos RD
    J Clin Endocrinol Metab; 2024 Jun; 109(7):e1544-e1545. PubMed ID: 38108434
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased lipoprotein(a) levels in children with familial hypercholesterolaemia.
    Widhalm K; Genser D
    Lancet; 1988 Nov; 2(8622):1262. PubMed ID: 2904000
    [No Abstract]   [Full Text] [Related]  

  • 19. Familial hypercholesterolaemia--report of two cases.
    Karnik ND; Pandit SP; Vyawahare S; Khokhani RC
    Indian Heart J; 1990; 42(5):385-7. PubMed ID: 2086446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study.
    Raal FJ; Hovingh GK; Blom D; Santos RD; Harada-Shiba M; Bruckert E; Couture P; Soran H; Watts GF; Kurtz C; Honarpour N; Tang L; Kasichayanula S; Wasserman SM; Stein EA
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):280-290. PubMed ID: 28215937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.